Editas Medicine, Inc. (EDIT) Q3 2022 Earnings Call Transcript
Editas Medicine, Inc. (NASDAQ:EDIT) Q3 2022 Earnings Conference Call November 2, 2022 8:00 AM ET Company Participants Ron Moldaver – Investor Relations Gilmore O’Neill – Chief Executive Officer Baisong Mei – Chief Medical Officer Mark […]
